• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care—CMS to Resume Risk Adjustment Payments and Other Health News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included CMS reversing its decision to suspend the risk adjustment payment program; out-of-pocket costs and copayment accumulators put an HIV prevention drug out of reach for patients; research finds geography can determine posttreatment imaging for women with breast cancer.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Read more about the stories in this podcast:

What We're Reading: Resuming Risk Adjustment Program; New Endometriosis Drug; Lilly Denounces Drug Imports

PrEP for HIV Prevention: Essential for Ending the Epidemic, but Out of Reach for Many

Geography Influences Type of Posttreatment Imaging Received After Early Breast Cancer

FDA Releases Biosimilar Action Plan

The Center for Biosimilars®

Related Videos
Patrick Sullivan, DVM, PhD
Dr Brian Mulherin
Dr Brian Koffman
Dr Brian Mulherin
Dr Vivek Subbiah
Dr Scott Soefje
Patrick Sullivan, DVM, PhD
Dr Scott Soefje
Dr Mark Fendrick
Dr Vishnukamal Golla
Related Content
The authors say more research is warranted to identify novel therapies that improve response and disease control in patients with ES-SCLC in the third line. | Image credit: Crystal light - stock.adobe.com

Real-World Outcomes From Third-Line SCLC Treatment Show Need for More Options

October 24th 2025
Article

Treatment options for patients with small cell lung cancer (SCLC) who survive to a third line of therapy are insufficient, authors of a new study argue.

Read More

The Evolution of AI Models in Mammography With Robert Nishikawa, PhD

The Evolution of AI Models in Mammography With Robert Nishikawa, PhD

October 23rd 2025
Podcast

AI-powered mammography is enhancing breast cancer screening and early detection through cutting-edge radiology insights.

Listen

Combining CAR T cells with first-line therapies like immune checkpoint inhibitors may ultimately prove to be the best method of deployment for CAR T in SCLC. | Image credit: Alpha Tauri 3D - stock.adobe.com

CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain

October 8th 2025
Article

Early research has identified several antigens that could help facilitate the use of chimeric antigen receptor T cells in small cell lung cancer.

Read More

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

October 14th 2025
Podcast

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Contributor: Why Public Health Keeps Failing—and How to Fix It

Contributor: Why Public Health Keeps Failing—and How to Fix It

October 7th 2025
Article

Public health must address emotional and structural inequities, emphasizes Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health.

Read More

Black woman holding HIV ribbon | Image credit: AS Photo Family

Withdrawal of Aid Could Cause Millions of Lives Lost to HIV

October 3rd 2025
Article

An epidemic resurgence is possible in Zambia should rapid restoration of HIV services not be conducted.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.